Administrative Core
行政核心
基本信息
- 批准号:10495742
- 负责人:
- 金额:$ 58.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-02-16 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAgingAgreementApplications GrantsAreaArkansasBioinformaticsBiologyBiomedical ResearchBone TissueBone remodelingCellular biologyCenters of Research ExcellenceCollaborationsCommunicationData SetDedicationsDepartment chairDevelopmentDevelopment PlansDiseaseDoctor of PhilosophyEndocrinologyEvaluationExtramural ActivitiesFacultyFosteringFoundationsFunctional disorderFundingGenetic ModelsGoalsGrowthHistologyHumanInfrastructureInstitutionLeadershipLearningMedicalMentorsMentorshipMolecularMusculoskeletalMusculoskeletal DiseasesMusculoskeletal SystemNamesOsteoblastsOsteocytesPeer ReviewPhasePhysiologyPilot ProjectsProductivityPublicationsPublishingRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch Project GrantsScienceScientistServicesStructureTeacher Professional DevelopmentUnited States National Institutes of HealthUniversitiesWorkbone imagingeffective therapyexperiencemembernegative affectoperationpeerprogramsrecruitskeletalsuccess
项目摘要
PROJECT SUMMARY/ABSTRACT – CORE A
Phase 1 of COBRE support established the Center for Musculoskeletal Disease Research (CMDR) at the
University of Arkansas for Medical Sciences (UAMS). The scientific theme of the CMDR is that identification of
molecular contributors to musculoskeletal dysfunction and disease will guide development of effective therapies.
The Center achieved key milestones during Phase 1, including mentoring and support of junior investigators to
the point of achieving independence, as defined by obtaining R01-level funding. These efforts, combined with
recruitment of established investigators, have significantly expanded the number of successful musculoskeletal
investigators in our Center. The three CMDR research cores established during Phase 1 also contributed to the
success of our junior investigators and other center members and significantly strengthened the biomedical
research infrastructure of our institution. An essential component of the effective operation of the CMDR was
establishment of the Administrative Core (Core A), which manages the infrastructure, oversight, and day-to-day
functioning of the Center. During Phase 2, the Administrative Core will continue to oversee all organizational and
budgetary aspects of the CMDR, supported by internal and external advisory committees (Aim 1). In addition,
the core will support CMDR growth via mentoring and a structured faculty development plan that will support
Project Leaders to point of R01-level funding (Aim 2). The Administrative Core will also recruit and promote the
development of new investigators via a Pilot Project Program, targeted recruitment of new investigators, and
evaluation of Center progress by the advisory committees (Aim 3). These goals will be accomplished under the
leadership of the Center Director and Associate Director who, with the support of experienced mentors and
advisory committees, will enable Project Leaders focused on musculoskeletal research to compete effectively
for R01-level funding. The Administrative Core will also oversee the operation of four Research Cores providing
state-of-the-art services to create new genetic models (Core B), perform specialized skeletal histology and bank
human bone tissue (Core C), provide bone imaging and quantification (Core D), and perform bioinformatic
analyses of large molecular datasets (Core E). The overall success of this strategy will be gauged by achieving
the following milestones within the five years of Phase 2 support: 1) three or more Project Leaders will obtain
R01-level research grant support; 2) three or more new Project Leaders will be selected and join the Center; 3)
Project Leaders and other Center members will publish between 25 and 50 peer-reviewed publications; and 4)
graduated Project Leaders and other members of the Center will develop productive collaborations and submit
a center-level grant application, such as a P01 or P30.
项目概要/摘要-核心A
COBRE支持的第一阶段在纽约建立了肌肉骨骼疾病研究中心(CMDR)。
阿肯色州医学科学大学。CMDR的科学主题是识别
肌肉骨骼功能障碍和疾病的分子贡献者将指导有效疗法的开发。
该中心在第1阶段实现了关键里程碑,包括指导和支持初级研究人员,
获得R 01级资金所定义的实现独立的点。这些努力,加上
招募既定的研究人员,大大增加了成功的肌肉骨骼
我们中心的调查员。在第一阶段建立的三个CMDR研究核心也有助于
我们的初级研究人员和其他中心成员的成功,大大加强了生物医学
我们机构的研究基础设施。CMDR有效运行的一个重要组成部分是
建立行政核心(核心A),负责管理基础设施、监督和日常事务。
中心的运作。在第二阶段,行政核心将继续监督所有组织和
CMDR的预算方面,由内部和外部咨询委员会提供支持(目标1)。此外,本发明还提供了一种方法,
核心将通过指导和结构化的教师发展计划来支持CMDR的发展,
项目领导人到R 01级供资点(目标2)。行政核心还将招募和促进
通过试点项目计划培养新研究者,有针对性地招募新研究者,以及
由咨询委员会对中心的进展情况进行评估(目标3)。这些目标将在
中心主任和副主任的领导,在经验丰富的导师的支持下,
咨询委员会,将使项目领导人专注于肌肉骨骼研究,以有效地竞争
R 01级融资。行政核心还将监督四个研究核心的运作,
最先进的服务,以创建新的遗传模型(核心B),进行专门的骨骼组织学和银行
人骨组织(核心C),提供骨成像和定量(核心D),并进行生物信息学
大型分子数据集的分析(核心E)。这一战略的总体成功将通过实现
在第二阶段支持的五年内实现以下里程碑:1)三个或更多项目负责人将获得
R 01级科研经费支持; 2)3名以上新项目负责人将被选拔加入中心; 3)
项目负责人和其他中心成员将发表25至50篇同行评审的出版物;以及4)
毕业的项目负责人和中心的其他成员将发展富有成效的合作,并提交
中心级补助申请,如P01或P30。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES A O'BRIEN其他文献
CHARLES A O'BRIEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES A O'BRIEN', 18)}}的其他基金
Center for Musculoskeletal Disease Research (CMDR)
肌肉骨骼疾病研究中心 (CMDR)
- 批准号:
10357772 - 财政年份:2018
- 资助金额:
$ 58.84万 - 项目类别:
Center for Musculoskeletal Disease Research (CMDR)
肌肉骨骼疾病研究中心 (CMDR)
- 批准号:
10495741 - 财政年份:2018
- 资助金额:
$ 58.84万 - 项目类别:
Center for Musculoskeletal Disease Research (CMDR)
肌肉骨骼疾病研究中心 (CMDR)
- 批准号:
10117257 - 财政年份:2018
- 资助金额:
$ 58.84万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 58.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




